The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Search
Most popular
COL·LABORA
Menu
English
Català
Español
Home
USR Barcelona
USR Barcelona
RESPONSABLE
Daniel Martínez Laguna
dmartinezl.bcn.ics@gencat.cat
Presentation
Team
Groups
Publications
Projects
News
Presentation
Team
Groups
Publications
Projects
News
Projects
Group projects
Ensayo Clínico sobre la efectividad y la tolerabcia de isoniacida y rifapentina administradas una vez por semana durante tres meses comparadas con la administración diaria de isoniacida sola durante nueve meses para el tratamiento de la infección tubercul
Principal investigators:
Joan Artur Caylà Buqueras
Code:
4R06/053
Start year:
2006
Funders:
Centers for Diseases Control
Estudio de las indicaciones, eficacia, tolerancia y coste de los tratamientos antituberculosos con pautas no estándar
Principal investigators:
Joan Artur Caylà Buqueras
Code:
4R06/054
Start year:
2006
Avaluar l’associació entre la inflamació sistèmica, mesurada amb la proteïna C reactiva (PCR), i els resultats clínics i funcionals de la malaltia
Principal investigators:
Ingrid Solanes García
Code:
4R06/055
Start year:
2006
Funders:
RESPIRA. Fundación Española del Pulmón. SEPAR
Evaluación de un modelo organizativo y de gestión en la atención de la enfermedad pulmonar obstructiva crónica.
Principal investigators:
Ignasi Bolíbar Ribas
Code:
4R07/074
Start year:
2007
Funders:
Instituto de Salud Carlos III
Evaluación de una pauta basada en sustituir isoniacida por moxifloxacino para el tratamiento de la tuberculosis (Estudio 28)
Principal investigators:
Joan Artur Caylà Buqueras
Code:
4R08/058
Start year:
2008
Funders:
Centers for Diseases Control
Anterior
1
…
108
109
110
111
112
…
211
Següent
Board of Trustees
Collaborators
Accreditations